Search for: "United States v. Sandoz"
Results 141 - 160
of 203
Sorted by Relevance
|
Sort by Date
5 Jan 2010, 10:56 am
UPDATE, Jan. 7: Today United States v. [read post]
2 Jun 2011, 12:46 pm
State, 686 S.E.2d 483, 485-86 (Ga. [read post]
26 Jun 2008, 6:31 pm
Matkari, 7 F.3d 1130, 1139 (4th Cir. 1993); Sandoz Pharmaceuticals v. [read post]
11 Jan 2017, 7:19 am
Sandoz Inc. v. [read post]
15 Apr 2010, 9:20 am
Matkari, 7 F.3d 1130, 1139 (4th Cir. 1993); Sandoz Pharmaceuticals Corp. v. [read post]
16 Jun 2015, 7:22 am
., United States v. [read post]
12 Jun 2014, 8:48 pm
After a four-day bench trial, the United States District Court for the District of Delaware found claim 8 of U.S. [read post]
4 Feb 2015, 1:52 pm
., Inc. v. [read post]
1 Apr 2016, 8:22 am
First Quality Baby Products, LLC, et al., No. 15-927 (three amici filed in support) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
23 Sep 2017, 12:39 pm
Sandoz, Inc., 789 F.3d 1335, 1344-45 (Fed. [read post]
25 Jan 2007, 12:48 am
United States, 17 F.3d 890, 901 (6th Cir. 1994); Albrecht v. [read post]
3 Apr 2014, 2:49 pm
United States, 13-632. [read post]
28 Sep 2009, 7:45 pm
Astrazeneca Pharma v. [read post]
13 Jul 2021, 6:11 am
Apotex NV, Mylan BV and Sandoz NVAfter the CJEU introduced the concept of “core inventive advance” in its Actavis v. [read post]
18 Feb 2010, 10:34 am
Mylan followed Sandoz Pharmaceuticals Corp. v. [read post]
5 Jul 2007, 10:37 am
United States, 740 F.2d 1428, 1440 (8th Cir. 1984); Madsen v. [read post]
28 Jun 2016, 6:41 am
United States District Court for the Eastern District of Michigan, et al., No. 15-1314 Commonwealth Scientific and Industrial Research Organisation v. [read post]
3 May 2016, 1:42 am
Dialogue, 27 U.S. 1 (1829) United States v. [read post]
19 Jul 2007, 1:47 pm
Wayne v. [read post]
27 Nov 2018, 9:30 am
CLS Bank), and equally far from the intricate statutory problems presented in cases like Sandoz v Amgen (assessing procedures for approving biosimilar pharmaceuticals). [read post]
